OxyContin Maker Reaches $270 Million Settlement with Oklahoma

HeadlineMar 27, 2019

The state of Oklahoma has reached a $270 million agreement with Purdue Pharma—the makers of OxyContin—settling a lawsuit that claimed the company contributed to the deaths of thousands of Oklahoma residents by downplaying the risk of opioid addiction and overstating the drug’s benefits. As part of the settlement, more than $100 million will fund a new addiction treatment and research center at Oklahoma State University in Tulsa. This is the first settlement Purdue has made amid some 2,000 additional lawsuits connecting its painkiller OxyContin to the opioid crisis. After headlines, we’ll spend the rest of the hour looking at the opioid crisis.

Topics:
The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Up arrowTop